| Catalog No. | Size | Price (USD) |
| 12186-MM05-50 | 50 µL | $147.96 |
| 12186-MM05-100 | 100 µL | $251.64 |
| 12186-MM05-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-GRO gamma/CXCL3 Antibody, Mouse Monoclonal |
| Validated applications | ELISA (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human GRO gamma/CXCL3 |
| Immunogen | Recombinant Human CXCL3 / GRO gamma Protein (Catalog#12186-H07E) |
| Preparation | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CXCL3 / GRO gamma (rh CXCL3 / GRO gamma; Catalog#12186-H07E; NP_002081.2; Ala35-Asn107). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| Source | Monoclonal Mouse IgG1 Clone #05 |
| Purification | Protein A |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-CINC-2b Antibody; Anti-GRO3 Antibody; Anti-GROg Antibody; Anti-MIP-2b Antibody; Anti-MIP2B Antibody; Anti-SCYB3 Antibody
Background Information
| Full Name | chemokine (C-X-C motif) ligand 3 |
| Description | CXCL3 is involved in migration, invasion, proliferation and tubule formation of trophoblasts and may play a key role in the pathogenesis of preeclampsia. CXCL3 autocrine/paracrine pathways are involved in the development of prostate cancer by regulating the expression of the target genes that are related to the progression of malignancies. CXCL3 is a novel adipokine that facilitates adipogenesis in an autocrine and/or a paracrine manner through induction of c/ebpb and c/ebpd. CXCL3 and its receptor CXCR2 are overexpressed in prostate cancer cells, prostate epithelial cells and prostate cancer tissues, which may play multiple roles in prostate cancer progression and metastasis. |
